This is in accordance with the literature, which frequently describes lower ADAMTS‐13 and higher VWF levels in cancer patients, often also in a stage‐dependent intensity.9, 10, 11, 12, 16, 20, 22, 23, 24, 25, 26, 27, 28. This evidence concerns the gene ADAMTS13 and cancer.